APA (7th ed.) Citation

TJ, G., F, O., A, C., N, P., JL, F., D, P., & DJ, K. (2026). Sustained response after rilzabrutinib discontinuation in multirefractory immune thrombocytopenia. Blood vessels, thrombosis & hemostasis, 3(2), 100167. https://doi.org/10.1016/j.bvth.2026.100167

Chicago Style (17th ed.) Citation

TJ, González-López, Orza F, Cuesta-García A, Pérez-Gómez N, Fedele JL, Provan D, and Kuter DJ. "Sustained Response After Rilzabrutinib Discontinuation in Multirefractory Immune Thrombocytopenia." Blood Vessels, Thrombosis & Hemostasis 3, no. 2 (2026): 100167. https://doi.org/10.1016/j.bvth.2026.100167.

MLA (9th ed.) Citation

TJ, González-López, et al. "Sustained Response After Rilzabrutinib Discontinuation in Multirefractory Immune Thrombocytopenia." Blood Vessels, Thrombosis & Hemostasis, vol. 3, no. 2, 2026, p. 100167, https://doi.org/10.1016/j.bvth.2026.100167.